MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Could These Devices Someday Replace Drugs? Cephaly


Cefaly, made by Cefaly Technology, uses low-frequency neurostimulation targeted at the trigeminal nerve to treat and prevent migraine headaches. Available via prescription, the device can provide an alternative to medication for some patients. Cephaly was cleared through FDA’s de novo pathway in March 2014.

[video courtesy of CEFALY TECHNOLOGY]  

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.